Yardeni: Stock market has a bad breadth problem
The stock market is facing a “bad breadth problem,” according to Yardeni Research analysts. Analysts explained in a note...
Welcome to the Trending News section of Finblog.com, your go-to source for the latest and most relevant updates in the financial world. This category is designed to keep you informed about the most current events, breaking news, and hot topics that are shaping the financial landscape.
Jefferies raises Airbnb numbers on expected Olympics boost
Jefferies analysts are bullish on Airbnb (NASDAQ: ABNB), citing a surge in bookings for the upcoming Paris Olympics. In...
Jefferies sees upside in Nvidia, raises target
Jefferies analysts are bullish on Nvidia (NASDAQ: NVDA), increasing their price target to $150 from $135 per share. This...
Top 5 things to watch in markets in the week ahead
U.S. Inflation and Rate Moves: Investors will closely watch the U.S. inflation gauge, the personal consumption expenditures price index,...
Street calls of the week: Micron downgrade, upgrade for Kroger
JPMorgan Upgrades Ollie’s Bargain Outlet to Overweight Ollie’s Bargain Outlet Holdings Inc. (NASDAQ: OLLI) received an upgrade to Overweight...
5 big analyst AI moves: Palantir downgraded, Micron PT hiked ahead of earnings
Microsoft “Best Way to Play AI,” Says Truist Truist Securities has named Microsoft (NASDAQ) as the top pick for...
Britvic rejects Carlsberg’s takeover offer; shares surge
Britvic (LON) announced Friday it has rejected two takeover proposals from Danish brewer Carlsberg (CSE), deeming them undervalued. The...
China Urges Visa and Mastercard to Slash Transaction Fees
China is pushing Visa (NYSE) and Mastercard (NYSE) to reduce their bank card transaction fees for foreign visitors, Bloomberg...
Should Investors Focus on Commodities in Q3 2024?
As the global economy faces ongoing challenges, analysts suggest paying close attention to key commodities entering the third quarter...
Sarepta Therapeutics surges 32% on expanded FDA approval for Duchenne gene therapy
Sarepta Therapeutics (NASDAQ) saw its shares soar 32% at market open on Friday following the FDA’s expanded approval of...